...
首页> 外文期刊>Diabetes, obesity & metabolism >Erratum: Effect of GLP GLP ‐1 receptor agonist treatment on body weight in obese antipsychotic‐treated patients with schizophrenia: A randomized, placebo‐controlled trial
【24h】

Erratum: Effect of GLP GLP ‐1 receptor agonist treatment on body weight in obese antipsychotic‐treated patients with schizophrenia: A randomized, placebo‐controlled trial

机译:错误:GLP GLP -1受体激动剂治疗对肥胖抗精神病治疗患者体重的影响:随机,安慰剂对照试验

获取原文
获取原文并翻译 | 示例

著录项

  • 来源
    《Diabetes, obesity & metabolism 》 |2018年第5期| 共2页
  • 作者单位

    Centre for Neuropsychiatric Schizophrenia Research CNSR and Center for Clinical Intervention and;

    Centre for Neuropsychiatric Schizophrenia Research CNSR and Center for Clinical Intervention and;

    Centre for Neuropsychiatric Schizophrenia Research CNSR and Center for Clinical Intervention and;

    Centre for Neuropsychiatric Schizophrenia Research CNSR and Center for Clinical Intervention and;

    Department of Clinical Physiology Nuclear Medicine &

    PETRigshospitalet University of;

    Departments of Clinical Biochemistry and Medicine Research Centre for Ageing and;

    Novo Nordisk Foundation Centre for Basic Metabolic Research Faculty of Health and Medical;

    Department of Clinical Medicine Faculty of Health and Medical SciencesUniversity of;

    Centre for Neuropsychiatric Schizophrenia Research CNSR and Center for Clinical Intervention and;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 内分泌腺疾病及代谢病 ;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号